We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+4.55%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.29B
AUM Growth
+$383M
Cap. Flow
+$337M
Cap. Flow %
10.23%
Top 10 Hldgs %
35.01%
Holding
141
New
13
Increased
43
Reduced
18
Closed
25

Top Buys

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$38.1M
2
TMX
Terminix Global Holdings, Inc.
TMX
+$35.9M
3
EXAS
Exact Sciences
EXAS
+$35.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$33.8M
5
MYOV
Myovant Sciences Ltd.
MYOV
+$27.1M

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$34.5M
2
ALTR
Altair Engineering Inc
ALTR
+$23.1M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$22.9M
4
OPLN
Openlane
OPLN
+$21.6M
5
QURE icon
uniQure
QURE
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 47.89%
2 Technology 19.59%
3 Industrials 8.32%
4 Consumer Discretionary 7.68%
5 Communication Services 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENE icon
76
Xenon Pharmaceuticals
XENE
$6.06B
$12.6M 0.38%
1,274,100
+653,409
+105% +$6.25M
XNCR icon
77
Xencor
XNCR
$1.5B
$12.3M 0.37%
300,000
+97,000
+48% +$3.19M
MDCO
78
DELISTED
Medicines Co
MDCO
$12.2M 0.37%
335,000
– –
MIC
79
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$11.7M 0.36%
289,000
-36,500
-11% -$1.5M
ADVM
80
DELISTED
Adverum Biotechnologies
ADVM
$8.56M 0.26%
72,000
-42,658
-37% -$3.53M
ARYAU
81
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
$8.55M 0.26%
800,000
– –
EXR icon
82
Extra Space Storage
EXR
$31.3B
$8.49M 0.26%
80,000
– –
MGNX icon
83
MacroGenics
MGNX
$235M
$8.23M 0.25%
485,000
– –
HSACU
84
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
$7.21M 0.22%
+680,000
New +$7.08M
ETTX
85
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$5.52M 0.17%
879,541
– –
THOR
86
DELISTED
Synthorx, Inc. Common Stock
THOR
$5.4M 0.16%
400,000
– –
BLUE
87
DELISTED
bluebird bio
BLUE
$4.58M 0.14%
2,779
-19,967
-88% -$34.5M
ORTX
88
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$3.78M 0.11%
27,000
– –
GYRE icon
89
Gyre Therapeutics
GYRE
$641M
$3.41M 0.1%
61,714
– –
SVRA icon
90
Savara
SVRA
$1.12B
$3.32M 0.1%
+1,400,000
New +$12.4M
EPIX
91
DELISTED
ESSA Pharma
EPIX
$3.22M 0.1%
1,385,169
+903,198
+187% +$2.23M
UROV
92
DELISTED
Urovant Sciences Ltd.
UROV
$3.18M 0.1%
401,558
-267,442
-40% -$2.19M
FENC icon
93
Fennec Pharmaceuticals
FENC
$332M
$2.88M 0.09%
720,000
– –
BEP icon
94
Brookfield Renewable
BEP
$9.97B
$2.75M 0.08%
149,182
+1,877
+1% +$32.4K
NEE icon
95
NextEra Energy
NEE
$181B
$2.54M 0.08%
+49,600
New +$2.44M
TT icon
96
Trane Technologies
TT
$100B
$2.53M 0.08%
20,000
+14,000
+233% +$1.67M
ERIC icon
97
Ericsson
ERIC
$32.2B
$2.47M 0.08%
260,000
+158,500
+156% +$1.54M
FHB icon
98
First Hawaiian
FHB
$3.38B
$2.43M 0.07%
94,000
– –
ARE icon
99
Alexandria Real Estate Equities
ARE
$8.97B
$2.43M 0.07%
17,200
+9,700
+129% +$1.4M
WM icon
100
Waste Management
WM
$90.6B
$2.25M 0.07%
+19,500
New +$2.12M
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Eventide Asset Management held 141 positions worth $3.29B, up 13% from $2.91B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Eventide Asset Management deployed $337M of net new capital in Q2 2019, opening 13 new positions and adding to 43 existing holdings. Its largest new stake was Terminix Global Holdings, Inc.: 698,000 shares worth $36.4M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 47% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was bluebird bio, an estimated $34.5M trimmed.

  • Eventide Asset Management's largest Q2 2019 buy was Terminix Global Holdings, Inc.: 698,000 shares worth $36.4M.
  • Eventide Asset Management added most to Zogenix, Inc. in Q2 2019, an estimated $38.1M increase.
  • Eventide Asset Management's biggest Q2 2019 reduction was bluebird bio, cutting an estimated $34.5M.
  • Eventide Asset Management fully exited Altair Engineering Inc in Q2 2019, selling an estimated $23.1M.
  • Eventide Asset Management's ten largest holdings make up 35% of its $3.29B portfolio in Q2 2019.
  • Eventide Asset Management opened 13 new positions and closed 25 in Q2 2019.
  • Eventide Asset Management's portfolio value rose 13% quarter-over-quarter to $3.29B.

Based on Eventide Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.